Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 2;162(12):bqab188. doi: 10.1210/endocr/bqab188

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 4. — Correlations of fatty acid (FA)-uptake–driven adipogenesis by guanosine 5′-diphosphate (GDP) treatment with levels of oxidative-phosphorylation (OXPHOS)/glycolysis–adenosine 5′-triphosphate (ATP) in preadipocytes/fibroblasts (PFs) from Graves orbitopathy orbital adipose tissue (OAT-GO). The scatterplot showing the relationship between percentage induced FA-uptake–driven adipogenesis by GDP + FA vs FA only, and levels of A, OXPHOS-ATP (dot); B, glycolysis-ATP (triangle); and C, the percentage ratio of OXPHOS/glycolysis (square) in nondifferentiating-PFs at basal day 0; or D, OXPHOS-ATP levels; E, glycolysis-ATP levels; and F, the percentage ratio of OXPHOS/glycolysis of differentiating PFs on day 4 adipogenesis. Statistically significant Pearson correlations for normally distributed data are underlined.